Deep Medicine Acquisition Corp. (NASDAQ:DMAQR) Short Interest Up 825.8% in August

Deep Medicine Acquisition Corp. (NASDAQ:DMAQRGet Free Report) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 28,700 shares, a growth of 825.8% from the August 15th total of 3,100 shares. Based on an average trading volume of 54,400 shares, the days-to-cover ratio is currently 0.5 days.

Deep Medicine Acquisition Stock Performance

Shares of NASDAQ:DMAQR opened at $0.30 on Thursday. The business has a 50 day moving average price of $0.25 and a 200 day moving average price of $0.18. Deep Medicine Acquisition has a twelve month low of $0.02 and a twelve month high of $0.44.

Hedge Funds Weigh In On Deep Medicine Acquisition

A hedge fund recently bought a new stake in Deep Medicine Acquisition stock. Highbridge Capital Management LLC purchased a new stake in Deep Medicine Acquisition Corp. (NASDAQ:DMAQRFree Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 200,000 shares of the company’s stock, valued at approximately $28,000.

Deep Medicine Acquisition Company Profile

(Get Free Report)

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.

Recommended Stories

Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with's FREE daily email newsletter.